High Density Lipoprotein Inhibits Assembly of Amyloid β-Peptides into Fibrils

Selkoe, 1994, Cell biology of the amyloid β protein precursor and the mechanism of Alzheimer's disease, Annu. Rev. Cell Biol., 10, 373, 10.1146/annurev.cb.10.110194.002105 Kirschner, 1987, Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro, Proc. Natl. Acad. Sci. USA, 84, 6953, 10.1073/pnas.84.19.6953 Jensen, 1997, Binding of Aβ to α- and β-synucleins: Identification of segments in α-synuclein/NAC precursor that binds Aβ and NAC, Biochem. J., 323, 539, 10.1042/bj3230539 Inestrosa, 1996, Acetylcholinesterase accelerates assembly of amyloid β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme, Neuron, 16, 881, 10.1016/S0896-6273(00)80108-7 Fraser, 1992, Effects of sulfate ions on Alzheimer-β/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions, J. Neurochem., 59, 1531, 10.1111/j.1471-4159.1992.tb08470.x Bush, 1994, Rapid induction of Alzheimer Aβ amyloid formation by zinc, Science, 265, 1464, 10.1126/science.8073293 Oda, 1995, Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ(1-42)) and forms slowly sedimenting Aβ complexes that cause oxidative stress, Exp. Neurol., 136, 22, 10.1006/exnr.1995.1080 Wood, 1996, Selective inhibition of Abeta fibril formation, J. Biol. Chem., 271, 4086, 10.1074/jbc.271.8.4086 Lorenzo, 1994, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red, Proc. Natl. Acad. Sci. USA, 91, 12243, 10.1073/pnas.91.25.12243 Strittmatter, 1996, Apolipoprotein E and Alzheimer's disease, Annu. Rev. Neurosci., 19, 53, 10.1146/annurev.ne.19.030196.000413 Boyles, 1985, Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system, J. Clin. Invest., 76, 1501, 10.1172/JCI112130 Rebeck, 1993, Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions, Neuron, 11, 575, 10.1016/0896-6273(93)90070-8 Pitas, 1987, Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain, J. Biol. Chem., 262, 14352, 10.1016/S0021-9258(18)47945-8 Strittmatter, 1993, Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 8098, 10.1073/pnas.90.17.8098 Castano, 1995, Fibrillogenesis in Alzheimer's disease of amyloid β-peptides and apolipoprotein E, Biochem. J., 306, 599, 10.1042/bj3060599 LaDu, 1994, Isoform-specific binding of apolipoprotein E to beta-amyloid, J. Biol. Chem., 269, 23403, 10.1016/S0021-9258(17)31529-6 Koudinov, 1996, Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins, Biochem. Biophys. Res. Commun., 223, 592, 10.1006/bbrc.1996.0940 Scharnagl, 1999, The βA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway, Lab Invest., 79, 1271 Cole, 1999, Lipoprotein effects on Aβ accumulation and degradation by microglia in vitro, J. Neurosci. Res., 57, 504, 10.1002/(SICI)1097-4547(19990815)57:4<504::AID-JNR10>3.0.CO;2-H Farhangrazi, 1997, High density lipoprotein decreases β-amyloid toxicity in cortical cell culture, Neuroreport, 8, 1127, 10.1097/00001756-199703240-00013 Wisniewski, 1994, Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145, 1030 LeVine, 1993, Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution, Protein Sci., 2, 404, 10.1002/pro.5560020312 Podlisny, 1995, Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture, J. Biol. Chem., 270, 9564, 10.1074/jbc.270.16.9564 Davignon, 1988, Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis, 8, 1, 10.1161/01.ATV.8.1.1 Weisgraber, 1990, Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112, J. Lipid Res., 31, 1503, 10.1016/S0022-2275(20)42621-5